1Ungerstedt U. 6-Hydroxydopamine induced degeneration of central monomine neurons [J]. Eur J Pharmacol, 1968, 5(1):107-110.
2Brundin P,Isacson O,Gage FH,et al. The rotating 6-OHDA-Lesioned mouse as a model for assessing functional effects of neu ronal grafting[J]. Brain Res,1986,366(1) :346-349.
3Vander P, Wiederhold KH, Probst A, et al. Neurolpathology in mice expressing human alphasynuclein [J]. Neuroscience, 2000,20(2): 6021-6029.
4Thomas J,Wang J,Takubo H,et al. A 6-OHDA induced selective parkinsonian rat model further biochemical and behavioral characterization [J]. Exp Neurol, 1994,126:159-167.
5Tseng JL, baetge EE, Zurn AD,et al. GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine[J]. J Neurosci, 1997,17: 325-333.
6Brecknell JE,Dunnett SB,Fawcett JW,et al. A quantitative study of cell death in the substantia nigra following a mechanical lesion of the medial forebrain bundle [J]. Neuroscience, 1995,64: 219-227.
7Bankiewicz KS, Oldfield EH,Chiueh CC,et al Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of MPTP [J]. Life Sci,1986,39:7.
8Johannessen JN,Chiueh CC, Burns RS, et al,Differense in the metabism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects [J]. Life Sci, 1985,36(3) :219-224.
9Betarbet R,Sherer TB, Mackenzie G,et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease [J]. Nat Neurosci,2000,20(3) :1301-1306.
10Hitoo N, Hideki H,Norie T,et al. Mesencephalic neural stem (Progenitor) cells develop to dopaminergic neurons more strongly in doparmine-depleted striatum than in intact striatum[J]. Exp Neurology, 2000,164: 209-214.
2Farooqui T, Farooqui AA. Lipid-mediated oxidative stress and inflam- mation in the pathogenesis of Parkinson' s disease [ J ]. Park Dis, 2011,15:247467.
3Dawson TM,Dawson VL. Molecular pathways of neurodegeneration in Parkinson' s disease[J]. Science,2003,302: 819-822.
4Chapuis S, Ouchchane L, Metz O, et al. Impact of the motor compli- cations of Parkinson' s disease on the quality of life[ J~. Mov Disord, 2005,20(2) : 224-230.
5Takagi Y, Takahashi J, Saiki H, et al. Dopaminergic neurons genera- ted from monkey embryonic stem cells function in a Parkinson primate model[ J ]. J Clin Invest,2005,115 : 102-109.
6Kikuchi T, Morizane A, Doi D, et al. Survival of human induced plu- ripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primatemodel of Parkinson' s disease [ J ]. J Parkinsons Dis, 2011,1(4) :395-412.
7Manuelpillai U, Moodley Y, Borlongan CV, et al. Amniotic membran~ and amnlotic cells: potential therapeutic tools to combat tissue in- flammation and fibrosis [ J ]. Placenta, 2011 ; 32 ( Suppl 4 ) : $320. $325.
8Parolini O,Alviano F, Bagnara GP,et al. Concise review: isolation and characterization of ceils from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells [ J]. Stem CeUs,2007, 26(2) :300-311.
9Akle CA,Adinolfi M,Welsh KI,et al. rmmunogenicity of human am- niotic epithelial ceils after transplantation into volunteers [ J ]. Lan- cet, 1981, 2 : 1003-1005.
10Leaver KR, Allbutt HN, Creber N J, et al. Oral pre:treatment with epigallocatechin gallate in 6-OHDA lesioned rats produces subtle symptomatic relief but neuroprotection [ J ]. Brain Res Bull,2009, 80(6) :397-402.
